Opportunities and challenges for the development of M1 muscarinic receptor positive allosteric modulators in the treatment for neurocognitive deficits

By tracie-pierce

December 13, 2022

Nguyen HTM, Valant C, van der Westhuizen ET, Langmead CJ, Tobin AB, Sexton PM, Christopoulos A (2024). Br J Pharmacol, 181(14):2114-2142. https://doi.org/10.1111/bph.15982

Continue exploring

Opportunities and challenges for the development of M1 muscarinic receptor positive allosteric modulators in the treatment for neurocognitive deficits

Continue exploring

Monash University

University of Melbourne

The Walter and Eliza Hall Institute